Technology News and Research

RSS

FDA approves Orexo's Zubsolv for people suffering from opioid dependence

Orexo today announced that it has received approval from the U.S. Food and Drug Administration for Zubsolv (buprenorphine/naloxone) sublingual tablet CIII.

4 Jul 2013

Royal Philips receives FDA clearance to market AlluraClarity live image guidance system in US

Royal Philips today announced that it has received 510(k) clearance from the US Food and Drug Administration to market its innovative AlluraClarity live image guidance system in the US.

From Philips Healthcare 4 Jul 2013

Assay identifies T cells as most capable of fighting infections and cancers

The idea of fighting infections and even cancers by inducing protective immune responses may now be a step closer to clinical practice. Researchers have removed a major obstacle to widespread use of so-called adoptive transfer therapy, in which a patient receives "killer" immune cells targeting a disease agent. Existing technologies can easily provide T cells that will recognize a specific antigen, but it has been challenging to identify individual cells most likely to succeed in fighting the disease - until now.

4 Jul 2013

Endoscopic imaging: an interview with Len Farris, Vice President of Marketing, Americas, PENTAX Medical

The impact of endoscopic imaging on patient care has been enormous since the first fiber optic systems were introduced more than 50 years ago. Today, high resolution and high definition systems are used to provide clinicians and patients unprecedented images from inside the body.

From PENTAX Medical Company 3 Jul 2013

CRB Bio II, ADE Capital Sodical commit €3M seed investment round in Raman Health Technologies

CRB Bio II, a VC Fund managed by CRB Inverbío, and ADE Capital Sodical, have committed a €3M seed investment round in Raman Health Technologies, a new start up company developing a new non invasive diagnostic technology platform based on Raman laser and Infrarred spectroscopy. Its first indication will be for the early diagnosis of Alzheimer disease in a blood sample.

3 Jul 2013

Imaxio receives FP7 grant to support the development of S. aureus vaccine

Imaxio, a biopharmaceutical company specialized in vaccines, together with its partners from the Jenner Institute at Oxford University, the European Vaccine Initiative and Preclin Biosystems, is pleased to announce today a European Union award of EUR 5.5 million to support the ‘Bellerophon Project’ consortium to develop a vaccine against Staphylococcus aureus (S. aureus).

3 Jul 2013

Sartorius launches new Sartocheck 4 plus Bag tester

Sartorius Stedim Biotech (SSB), a leading international equipment supplier for the pharma and biotech industries, has launched the new Sartocheck 4 plus Bag tester, the latest addition to its well-established Sartocheck line.

From Sartorius 3 Jul 2013

Texas protesters, lawmakers ready for committee clashes on abortion bill

Protesters and lawmakers gird for a new day of debate on Texas' proposal to ban abortions after 20 weeks of pregnancy as well as enact regulations some activists say will shutter all but a few of the state's abortion clinics.

3 Jul 2013

LCS, CareSouth announce joint venture partnership in Health at Home

LCS, a national leader in senior lifestyle services and senior living community development and management, and CareSouth®, a leading regional provider of home health services, are pleased to announce a joint venture partnership in Health at Home, An LCS Company.

3 Jul 2013

Two-dimensional barcodes on vaccine improve safety of the U.S. immunization system, save millions

Using two-dimensional barcodes on vaccine product labels would enhance the safety of the U.S. immunization system and save more than $300 million by 2023, according to a study by researchers at RTI International and the U.S. Centers for Disease Control & Prevention.

3 Jul 2013

Biogen, Sobi present new findings from Phase 3 trial of ALPROLIX at XXIV ISTH Congress

Biogen Idec and Swedish Orphan Biovitrum AB (publ) today presented new findings for their long-lasting recombinant factor IX candidate ALPROLIX for hemophilia B at the XXIV International Society on Thrombosis and Haemostasis Congress in Amsterdam, The Netherlands.

3 Jul 2013

Chemist to develop inkjet-printed, nanoparticle-based test strips to detect disease-causing bacteria in drinking water

Today the National Academy of Sciences announced a three-year, $271,930 grant to chemist Vincent Rotello at the University of Massachusetts Amherst to develop, test and deploy new, sensitive, reliable and affordable inkjet-printed, nanoparticle-based test strips for detecting disease-causing bacteria in drinking water, with researchers at the Lahore University of Management Sciences (LUMS), Pakistan.

3 Jul 2013

Devon Medical gets ANVISA certification for extriCARE 2400 NPWT system

Devon Medical, a global medical device manufacturer, designer, and distributor, announced today that it has received medical device registration and approval from the Brazilian National Health Surveillance Agency (ANVISA - Agência Nacional de Vigilância Sanitária) for its extriCARE 2400 Negative Pressure Wound Therapy pump.

2 Jul 2013

West Pharmaceutical Services expands NovaGuard portfolio of needle safety products

West Pharmaceutical Services, Inc., a leading global developer and manufacturer of components and systems for injectable drug delivery, today announced the expansion of the NovaGuard portfolio of needle safety products.

2 Jul 2013

VIZZIA Technologies' clinical workflow optimization solution installed at FCS Tampa Cancer Center

VIZZIA Technologies, a leading provider of process and technology solutions, announced today that its clinical workflow optimization solution was recently installed at Florida Cancer Specialists & Research Institute's Tampa Cancer Center location.

2 Jul 2013

Nanofiber Solutions wins Ohio Third Frontier Technology Validation and Start-up Fund award

Nanofiber Solutions, LLC, in collaboration with Gail E. Besner, MD, chief of Pediatric Surgery, program director of the Residency in Pediatric Surgery and co-director of the Burn Program all at Nationwide Children's Hospital, recently was honored with the Ohio Third Frontier Technology Validation and Start-up Fund award.

2 Jul 2013

UH and Case Western Reserve University to develop diagnostic tests to determine HIV drug resistance

Case Western Reserve University has signed an exclusive worldwide licensing agreement granting University Hospitals Case Medical Center rights to a series of diagnostic tests to determine drug resistance and co-receptor tropism in human immunodeficiency virus.

2 Jul 2013

Technology News and Research

FDA approves Orexo's Zubsolv for people suffering from opioid dependence

Royal Philips receives FDA clearance to market AlluraClarity live image guidance system in US

Assay identifies T cells as most capable of fighting infections and cancers

Endoscopic imaging: an interview with Len Farris, Vice President of Marketing, Americas, PENTAX Medical

CRB Bio II, ADE Capital Sodical commit €3M seed investment round in Raman Health Technologies

Imaxio receives FP7 grant to support the development of S. aureus vaccine

Sartorius launches new Sartocheck 4 plus Bag tester

Texas protesters, lawmakers ready for committee clashes on abortion bill

LCS, CareSouth announce joint venture partnership in Health at Home

Two-dimensional barcodes on vaccine improve safety of the U.S. immunization system, save millions

Biogen, Sobi present new findings from Phase 3 trial of ALPROLIX at XXIV ISTH Congress

Chemist to develop inkjet-printed, nanoparticle-based test strips to detect disease-causing bacteria in drinking water

Devon Medical gets ANVISA certification for extriCARE 2400 NPWT system

West Pharmaceutical Services expands NovaGuard portfolio of needle safety products

VIZZIA Technologies' clinical workflow optimization solution installed at FCS Tampa Cancer Center

Nanofiber Solutions wins Ohio Third Frontier Technology Validation and Start-up Fund award

UH and Case Western Reserve University to develop diagnostic tests to determine HIV drug resistance

Scientists find new links in gene networks that control movement

Glide Pharma signs design optimisation agreement with Nypro Healthcare for solid dose injector

Arcam receives order for Arcam Q10 system from Implantcast in Germany

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News